Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Fink, JN; Wallis, WE; Haydock, DA
   Myasthenia gravis with thymoma is more common in the Maori and Pacific Island populations in New Zealand
   INTERNAL MEDICINE JOURNAL
   
   J.N. Fink et al., "Myasthenia gravis with thymoma is more common in the Maori and Pacific Island populations in New Zealand", INTERN M J, 31(4), 2001, pp. 206-210
2. Baba, M; Nomoto, Y; Iyoda, A; Saito, H; Hiroshima, K; Shibuya, K; Haga, Y; Hoshino, H; Iizasa, T; Horiuchi, F; Fujisawa, T
   Cytomorphologic features characteristic of tumor stages of thymomas
   ONCOLOGY REPORTS
   
   M. Baba et al., "Cytomorphologic features characteristic of tumor stages of thymomas", ONCOL REP, 8(5), 2001, pp. 1139-1143
3. Tateyama, H; Takahashi, E; Saito, Y; Fukai, I; Fujii, Y; Niwa, H; Eimoto, T
   Histopathologic changes of thymoma preoperatively treated with corticosteroids
   VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
   
   H. Tateyama et al., "Histopathologic changes of thymoma preoperatively treated with corticosteroids", VIRCHOWS AR, 438(3), 2001, pp. 238-247
4. Pan, CC; Chen, WYK; Chiang, H
   Spindle cell and mixed spindle/lymphocytic thymomas - An integrated clinicopathologic and immunohistochemical study of 81 cases
   AMERICAN JOURNAL OF SURGICAL PATHOLOGY
   
   C.C. Pan et al., "Spindle cell and mixed spindle/lymphocytic thymomas - An integrated clinicopathologic and immunohistochemical study of 81 cases", AM J SURG P, 25(1), 2001, pp. 111-120
5. Hattori, H; Tateyama, H; Tada, T; Saito, Y; Yamakawa, Y; Eimoto, T
   PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Muller-Hermelink classification - An immunohistochemical study using catalyzed signal amplification
   VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY
   
   H. Hattori et al., "PE-35-related antigen expression and CD1a-positive lymphocytes in thymoma subtypes based on Muller-Hermelink classification - An immunohistochemical study using catalyzed signal amplification", VIRCHOWS AR, 436(1), 2000, pp. 20-27
6. Engel, PJH
   Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA (EBER) in situ hybridization
   APMIS
   
   P.J.H. Engel, "Absence of latent Epstein-Barr virus in thymic epithelial tumors as demonstrated by Epstein-Barr-encoded RNA (EBER) in situ hybridization", APMIS, 108(6), 2000, pp. 393-397
7. Christiansen, S; Marx, A; Kiefer, R; Scheld, HH; Semik, M
   Small thymomas and myasthenia gravis: a poorly understood association
   THORACIC AND CARDIOVASCULAR SURGEON
   
   S. Christiansen et al., "Small thymomas and myasthenia gravis: a poorly understood association", THOR CARD S, 48(2), 2000, pp. 109-111
8. Gripp, S; Hilgers, K; Ploem-Zaaijer, JJ; Hartmann, A; Schmitt, G
   Prognostic significance of DNA cytometry in thymoma
   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
   
   S. Gripp et al., "Prognostic significance of DNA cytometry in thymoma", J CANC RES, 126(5), 2000, pp. 280-284
9. Ferone, D; van Hagen, MP; Kwekkeboom, DJ; van Koetsveld, PM; Mooy, DM; Lichtenauer-Kaligis, E; Schonbrunn, A; Colao, A; Lamberts, SWJ; Hofland, LJ
   Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro
   JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
   
   D. Ferone et al., "Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro", J CLIN END, 85(4), 2000, pp. 1719-1726
10. Hoffacker, V; Schultz, A; Tiesinga, JJ; Gold, R; Schalke, B; Nix, W; Kiefer, R; Muller-Hermelink, HK; Marx, A
    Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease
    BLOOD
    
    V. Hoffacker et al., "Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated autoimmune disease", BLOOD, 96(12), 2000, pp. 3872-3879
11. Schultz, A; Hoffacker, V; Wilisch, A; Nix, W; Gold, R; Schalke, B; Tzartos, S; Muller-Hermelink, HK; Marx, A
    Neurofilament is an autoantigenic determinant in myasthenia gravis
    ANNALS OF NEUROLOGY
    
    A. Schultz et al., "Neurofilament is an autoantigenic determinant in myasthenia gravis", ANN NEUROL, 46(2), 1999, pp. 167-175
12. Gattenlohner, S; Muller-Hermelink, HK; Marx, A
    Transcription of the nude gene (WHN) in human normal organs and mediastinal and pulmonary tumors
    PATHOLOGY RESEARCH AND PRACTICE
    
    S. Gattenlohner et al., "Transcription of the nude gene (WHN) in human normal organs and mediastinal and pulmonary tumors", PATH RES PR, 195(8), 1999, pp. 571-574
13. Marienhagen, J; Schalke, B; Aebert, H; Held, P; Eilles, C; Bogdahn, U
    Somatostatin receptor scintigraphy in thymoma imaging method and clinical application
    PATHOLOGY RESEARCH AND PRACTICE
    
    J. Marienhagen et al., "Somatostatin receptor scintigraphy in thymoma imaging method and clinical application", PATH RES PR, 195(8), 1999, pp. 575-581
14. Wilisch, A; Gutsche, S; Hoffacker, V; Schultz, A; Tzartos, S; Nix, W; Schalke, B; Schneider, C; Muller-Hermelink, HK; Marx, A
    Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis
    NEUROLOGY
    
    A. Wilisch et al., "Association of acetylcholine receptor alpha-subunit gene expression in mixed thymoma with myasthenia gravis", NEUROLOGY, 52(7), 1999, pp. 1460-1466
15. Ruffie, P; Gory-Delabaere, G; Fervers, B; Lehmann, M; Regnard, JF; Resbeut, M
    Standards, Options and Recommendations (SOR) for clinical care of malignant thymoma
    BULLETIN DU CANCER
    
    P. Ruffie et al., "Standards, Options and Recommendations (SOR) for clinical care of malignant thymoma", B CANCER, 86(4), 1999, pp. 365-384
16. YANG WI; YANG KM; HONG SW; KIM KD
    E-CADHERIN EXPRESSION IN THYMOMAS
    Yonsei medical journal
    
    W.I. Yang et al., "E-CADHERIN EXPRESSION IN THYMOMAS", Yonsei medical journal, 39(1), 1998, pp. 37-44
17. Pan, CC; Ho, DMT; Chen, WYK; Huang, CW; Chiang, H
    Ki67 labelling index correlates with stage and histology but not significantly with prognosis in thymoma
    HISTOPATHOLOGY
    
    C.C. Pan et al., "Ki67 labelling index correlates with stage and histology but not significantly with prognosis in thymoma", HISTOPATHOL, 33(5), 1998, pp. 453-458
18. NENNINGER R; SCHULTZ A; HOFFACKER V; HELMREICH M; WILISCH A; VANDEKERCKHOVE B; HUNIG T; SCHALKE B; SCHNEIDER C; TZARTOS S; KALBACHER H; MULLERHERMELINK HK; MARX A
    ABNORMAL THYMOCYTE DEVELOPMENT AND GENERATION OF AUTOREACTIVE T-CELLSIN MIXED AND CORTICAL THYMOMAS
    Laboratory investigation
    
    R. Nenninger et al., "ABNORMAL THYMOCYTE DEVELOPMENT AND GENERATION OF AUTOREACTIVE T-CELLSIN MIXED AND CORTICAL THYMOMAS", Laboratory investigation, 78(6), 1998, pp. 743-753
19. NAGVEKAR N; MOODY AM; MOSS P; ROXANIS I; CURNOW J; BEESON D; PANTIC N; NEWSOMDAVIS J; VINCENT A; WILLCOX N
    PATHOGENETIC ROLE FOR THE THYMOMA IN MYASTHENIA-GRAVIS - AUTOSENSITIZATION OF IL-4-PRODUCING T-CELL CLONES RECOGNIZING EXTRACELLULAR ACETYLCHOLINE-RECEPTOR EPITOPES PRESENTED BY MINORITY CLASS-II ISOTYPES
    The Journal of clinical investigation
    
    N. Nagvekar et al., "PATHOGENETIC ROLE FOR THE THYMOMA IN MYASTHENIA-GRAVIS - AUTOSENSITIZATION OF IL-4-PRODUCING T-CELL CLONES RECOGNIZING EXTRACELLULAR ACETYLCHOLINE-RECEPTOR EPITOPES PRESENTED BY MINORITY CLASS-II ISOTYPES", The Journal of clinical investigation, 101(10), 1998, pp. 2268-2277
20. NAGVEKAR N; JACOBSON LW; WILLCOX N; VINCENT A
    EPITOPES EXPRESSED IN MYASTHENIA-GRAVIS (MG) THYMOMAS ARE NOT RECOGNIZED BY PATIENTS T-CELLS OR AUTOANTIBODIES
    Clinical and experimental immunology
    
    N. Nagvekar et al., "EPITOPES EXPRESSED IN MYASTHENIA-GRAVIS (MG) THYMOMAS ARE NOT RECOGNIZED BY PATIENTS T-CELLS OR AUTOANTIBODIES", Clinical and experimental immunology, 112(1), 1998, pp. 17-20
21. TRAVIS WD
    PATHOLOGY OF PULMONARY PLEURAL, AND MEDIASTINAL MALIGNANCIES OTHER THAN LUNG-CARCINOMA
    Seminars in respiratory and critical care medicine
    
    W.D. Travis, "PATHOLOGY OF PULMONARY PLEURAL, AND MEDIASTINAL MALIGNANCIES OTHER THAN LUNG-CARCINOMA", Seminars in respiratory and critical care medicine, 18(4), 1997, pp. 313-332
22. SKEIE GO; FREIBURG A; KOLMERER B; LABEIT S; AARLI JA; APPIAHBOADU S; GILHUS NE
    TITIN TRANSCRIPTS IN THYMOMAS
    Journal of autoimmunity
    
    G.O. Skeie et al., "TITIN TRANSCRIPTS IN THYMOMAS", Journal of autoimmunity, 10(6), 1997, pp. 551-557
23. STEFANAKI K; RONTOGIANNI D; KOUVIDOU CH; BOLIOTI S; DELIDES G; PANTELIDAKI A; SOTSIOU F; KANAVAROS P
    EXPRESSION OF P53, MDM2, P21 WAF1 AND BCL-2 PROTEINS IN THYMOMAS/
    Histopathology
    
    K. Stefanaki et al., "EXPRESSION OF P53, MDM2, P21 WAF1 AND BCL-2 PROTEINS IN THYMOMAS/", Histopathology, 30(6), 1997, pp. 549-555
24. TSAI CC; CHEN CL; HSU HC
    EXPRESSION OF EPSTEIN-BARR-VIRUS IN CARCINOMAS OF MAJOR SALIVARY-GLANDS - A STRONG ASSOCIATION WITH LYMPHOEPITHELIOMA-LIKE CARCINOMA
    Human pathology
    
    C.C. Tsai et al., "EXPRESSION OF EPSTEIN-BARR-VIRUS IN CARCINOMAS OF MAJOR SALIVARY-GLANDS - A STRONG ASSOCIATION WITH LYMPHOEPITHELIOMA-LIKE CARCINOMA", Human pathology, 27(3), 1996, pp. 258-262
25. YANG WI; EFIRD JT; QUINTANILLAMARTINEZ L; CHOI N; HARRIS NL
    CELL KINETIC-STUDY OF THYMIC EPITHELIAL TUMORS USING PCNA (PC10) AND KI-67 (MIB-1) ANTIBODIES
    Human pathology
    
    W.I. Yang et al., "CELL KINETIC-STUDY OF THYMIC EPITHELIAL TUMORS USING PCNA (PC10) AND KI-67 (MIB-1) ANTIBODIES", Human pathology, 27(1), 1996, pp. 70-76
26. CLOSE PM; KIRCHNER T; UYS C; MULLERHERMELINK HK
    REPRODUCIBILITY OF A HISTOGENETIC CLASSIFICATION OF THYMIC EPITHELIALTUMORS
    Histopathology
    
    P.M. Close et al., "REPRODUCIBILITY OF A HISTOGENETIC CLASSIFICATION OF THYMIC EPITHELIALTUMORS", Histopathology, 26(4), 1995, pp. 339-343
27. PICH A; CHIARLE R; CHIUSA L; PONTI R; GEUNA M; CASADIO C; MAGGI G; PALESTRO G
    LONG-TERM SURVIVAL OF THYMOMA PATIENTS BY HISTOLOGIC PATTERN AND PROLIFERATIVE ACTIVITY
    The American journal of surgical pathology
    
    A. Pich et al., "LONG-TERM SURVIVAL OF THYMOMA PATIENTS BY HISTOLOGIC PATTERN AND PROLIFERATIVE ACTIVITY", The American journal of surgical pathology, 19(8), 1995, pp. 918-926
28. GILHUS NE; JONES M; TURLEY H; GATTER KC; NAGVEKAR N; NEWSOMDAVIS J; WILLCOX N
    ONCOGENE PROTEINS AND PROLIFERATION ANTIGENS IN THYMOMAS - INCREASED EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND KI67 ANTIGEN
    Journal of Clinical Pathology
    
    N.E. Gilhus et al., "ONCOGENE PROTEINS AND PROLIFERATION ANTIGENS IN THYMOMAS - INCREASED EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND KI67 ANTIGEN", Journal of Clinical Pathology, 48(5), 1995, pp. 447-455
29. KOGA K; MATSUNO Y; NOGUCHI M; MUKAI K; ASAMURA H; GOYA T; SHIMOSATO Y
    A REVIEW OF 79 THYMOMAS - MODIFICATION OF STAGING SYSTEM AND REAPPRAISAL OF CONVENTIONAL DIVISION INTO INVASIVE AND NONINVASIVE THYMOMA
    Pathology international
    
    K. Koga et al., "A REVIEW OF 79 THYMOMAS - MODIFICATION OF STAGING SYSTEM AND REAPPRAISAL OF CONVENTIONAL DIVISION INTO INVASIVE AND NONINVASIVE THYMOMA", Pathology international, 44(5), 1994, pp. 359-367
30. PICH A; CHIARLE R; CHIUSA L; PALESTRO G
    ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS PREDICT SURVIVAL IN THYMOMA
    Cancer
    
    A. Pich et al., "ARGYROPHILIC NUCLEOLAR ORGANIZER REGION COUNTS PREDICT SURVIVAL IN THYMOMA", Cancer, 74(5), 1994, pp. 1568-1574
31. QUINTANILLAMARTINEZ L; WILKINS EW; FERRY JA; HARRIS NL
    THYMOMA - MORPHOLOGIC SUBCLASSIFICATION CORRELATES WITH INVASIVENESS AND IMMUNOHISTOLOGIC FEATURES - A STUDY OF 122 CASES
    Human pathology
    
    L. Quintanillamartinez et al., "THYMOMA - MORPHOLOGIC SUBCLASSIFICATION CORRELATES WITH INVASIVENESS AND IMMUNOHISTOLOGIC FEATURES - A STUDY OF 122 CASES", Human pathology, 24(9), 1993, pp. 958-969